Talks between Pfizer and Allergan have raised the prospect of a mega-merger in the pharmaceutical industry as the broader US stock market finished slightly lower.

Talks between Pfizer and Allergan have raised the prospect of a mega-merger in the pharmaceutical industry as the broader US stock market finished slightly lower.